Navigation Links
Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
Date:6/3/2008

ulmonary and skeletal muscle function. Participants who complete the study may be eligible to participate in a voluntary extension study that will further evaluate the effect of AT2220 on these functional parameters.

Additional information about the Phase 2 study will be posted at ClinicalTrials.gov.

Initiation of the Phase 2 study of AT2220 follows completion of an ex vivo response study as well as multiple Phase 1 studies of AT2220 in healthy volunteers. The ex vivo response study was designed to test the effect of AT2220 on various Pompe mutations. Blood and skin samples were collected from 30 Pompe patients (26 adults, three juveniles and one infant) who had a variety of GAA mutations. Cells derived from each patient were then treated with AT2220. Of the 26 patients with available data, 24 had cells that showed a dose responsive increase in GAA activity including 22 patients who had at least one copy of the common splice site mutation IVS1-13T>G. Data from the Phase 1 studies in 72 healthy volunteers demonstrated that AT2220 was generally safe and well tolerated at all doses evaluated with no drug-related serious adverse events.

Amicus is developing AT2220 as part of a strategic collaboration with Shire Human Genetic Therapies (HGT), a business unit of Shire plc, to develop and commercialize Amicus' three lead pharmacological chaperone compounds for lysosomal storage disorders. Under the agreement, Shire received commercial rights outside of the United States. Amicus retains all U.S. rights.

About Pompe Disease

Pompe disease affects an estimated 5,000-10,000 individuals world-wide and is clinically heterogeneous in the age of onset, the extent of organ involvement, and the rate of progression. The early onset form of the disease is the most severe, progresses most rapidly, and is characterized by musculoskeletal, pulmonary, gastrointestinal, and cardiac symptoms that usually lead to death from cardio-respiratory failure between
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
2. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
3. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
9. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
10. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... CHAPEL HILL, N.C. , May 24, 2013 ... Affairs to the forefront of many organizations, priority ... biopharmaceutical and medical device sectors understand a strong ... meeting current challenges in clinical development, market ... operate effectively to create a vital bridge between ...
(Date:5/24/2013)... 2013  BD (Becton, Dickinson and Company) (NYSE: ... that it will present at the Deutsche Bank 38 th ... at 10:40 a.m. (ET). A live webcast ... website at www.bd.com/investors and will be available for ... BD BD is a leading global medical technology ...
(Date:5/24/2013)... May 24, 2013 /PRNewswire-iReach/ -- Phoenix Houses of ... abuse services organization, is hosting its tenth annual "Triumph ... on June 6, 2013.  More than 300 people are ... the adolescent residential treatment centers, family therapy, and prevention ... whose accomplishments have positive influences on the health and welfare ...
Breaking Medicine Technology:Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3
... At Heart Rhythm 2011, the Heart Rhythm Society,s 32nd annual ... (NYSE: PHG, AEX: PHI) and the Heart Rhythm Society (HRS) ... that shape the diagnosis and minimally invasive treatment of heart ... by disturbed electrical signals that regulate the heart and can ...
... Tulsa Shock guard Andrea Riley and Basketball Hall of Famer ... for Adolescent Health and Medicine (SAHM) today to bring ... for Teens is a national awareness campaign designed to ... against serious and potentially life-threatening diseases. To ...
Cached Medicine Technology:Philips and the Heart Rhythm Society Collaborate to Showcase the Electrophysiology (EP) Lab of Today and the Future 2Philips and the Heart Rhythm Society Collaborate to Showcase the Electrophysiology (EP) Lab of Today and the Future 3Tulsa Shock Guard Andrea Riley and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health 2Tulsa Shock Guard Andrea Riley and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health 3Tulsa Shock Guard Andrea Riley and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health 4Tulsa Shock Guard Andrea Riley and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health 5
(Date:5/24/2013)... Tampa, FL (PRWEB) May 24, 2013 Compromise ... wants to compromise when it comes to sleep and comfort. ... sleep preferences prove highly individual. For some, this can cause ... Bed, a mattress advice blog, tackles eight common issues in ... “ She Wants Soft, He Wants Firm: What to do ...
(Date:5/24/2013)... 2013 Range Kleen Mfg. strives to “TCOTC.” ... Customer, from the President's desk to the Shipping Dock.” We ... integrity, and having passion while creating excellence and quality being ... company to do the right thing and what better way ... affected by devastation. , Throughout the year Range Kleen donates ...
(Date:5/24/2013)... Park City, Utah (PRWEB) May 24, 2013 ... new information on the Indiana Health Insurance ... flexible alternatives to traditional employer sponsored health benefits, ... and health reimbursement arrangements . , ... as part of the Affordable Care Act (ACA), ...
(Date:5/24/2013)... Before you start the grill, before you watch the game, kick ... Hoda Kotb on the Today Show on Memorial Day. Carley ... Lee and Hoda, including the new LawnBott® LB75 robotic mower. ... the military who made the ultimate sacrifice for us. On ... and family and enjoy the day. With a LawnBott® robotic ...
(Date:5/24/2013)... This week is National EMS Week, ... to provide the best emergency care and to improve ... is also to educate the public that all can ... are the first link, and a very important one. ... after a cardiac arrest can triple a victim’s chance ...
Breaking Medicine News(10 mins):Health News:What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples 2Health News:Range Kleen Partners with Berndes in Red Cross Promotion: Taking Care of Oklahoma 2Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 3Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 4Health News:LawnBott® Visits the Today Show with Kathie Lee and Hoda 2Health News:Acadian Medics Reunite with Miracle Baby 2
... By Denise Mann HealthDay Reporter , ... hidden in the nape of the neck may mean ... don,t respond to other treatments, a new study suggests. ... which are marked by intense pain, sensitivity to light ...
... Tampa, FL (June 23, 2011) Education, referrals, support ... of screening mammography in the United States especially ... race and ethnicity is similar to that of the ... at the University of South Florida, Moffitt Cancer Center, ...
... some of the planet,s most deadly infections. In part ... diseases caused by so called Gram-positive bacteria. Now, a ... mechanism behind these deadly infections. By creating a ... chemist Christian Marcus Pedersen has made a contribution that,ll ...
... University has awarded seven new Environmental Venture Projects (EVP) ... promoting global sustainability. Seven faculty teams will ... a broad range of environmental challenges, from coral reefs ... seven projects were selected from an initial pool of ...
... HealthDay Reporter , WEDNESDAY, June 22 (HealthDay News) -- The ... of people in Europe and sickened thousands more may be ... new study suggests. Scientists say this strain of E. ... tenacious ability to hold on to cells within the intestine. ...
... case study that illustrates the need for people with diabetes to ... a woman with numbness in her feet caused by diabetic neuropathy ... chewed off part of her slightly infected big toe, according to ... of the American Podiatric Medical Association . The patient,s wound ...
Cached Medicine News:Health News:Implantable Device May Help Ease Tough Migraines 2Health News:Implantable Device May Help Ease Tough Migraines 3Health News:Community health worker interventions improve rates of US mammography screening 2Health News:Chemist solves riddle of killer diseases 2Health News:Stanford Woods Institute awards Environmental Venture Projects 2Health News:Stanford Woods Institute awards Environmental Venture Projects 3Health News:Stanford Woods Institute awards Environmental Venture Projects 4Health News:German E. Coli Strain Especially Lethal, Studies Find 2Health News:German E. Coli Strain Especially Lethal, Studies Find 3Health News:Cautionary tale for people with diabetes: Dog consumed part of a sleeping patient's toe 2
... safely, the Hoefer GD 2000 uses a dry-heat ... the gel through a heavy aluminum platen. , ... 33 x 44 cm in as little as ... heat distribution and even vacuum distribution under the ...
This double-up gel dryer system, 200-240 V, includes 2 Model 583 gel dryers, HydroTech™ vacuum pump, and double-up rack....
... The GelAir™ drying system utilizes a hot air ... are dried on a clear cellophane support for ... provide a smooth, flat assembly surface for the ... drying frames at once. This 115 V, 60 ...
The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 115 V, 60 Hz gel drying oven....
Medicine Products: